Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-06 4:12 pm Sale |
2023-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
Millennium Management LLC | 0 0.000% |
-2,433,850 (Position Closed) |
Filing History |
| 2024-02-01 4:15 pm Purchase |
2024-01-22 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
Venrock Healthcare Capital Partners III, L.P. | 4,428,385 6.600% |
4,428,385 (New Position) |
Filing History |
| 2024-01-30 4:31 pm Purchase |
2024-01-20 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
VIKING GLOBAL INVESTORS LP | 4,000,000 5.900% |
4,000,000 (New Position) |
Filing History |
| 2024-01-29 5:25 pm Purchase |
2023-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
BlackRock Inc. BLK |
3,095,648 5.700% |
2,296,307 (+287.28%) |
Filing History |
| 2024-01-25 1:24 pm Purchase |
2024-01-23 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
Frazier Life Sciences Public Fund, L.P. | 4,142,855 6.200% |
4,142,855 (New Position) |
Filing History |
| 2023-07-07 4:15 pm Purchase |
2023-06-27 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
Nextech Crossover I GP S.a r.l. | 4,285,714 7.900% |
4,285,714 (New Position) |
Filing History |
| 2023-06-09 8:15 pm Purchase |
2023-05-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
Prosight Management LP | 2,280,778 5.100% |
2,280,778 (New Position) |
Filing History |
| 2023-02-13 10:15 am Purchase |
2022-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
Alkeon Capital Management LLC | 2,399,252 6.100% |
2,399,252 (New Position) |
Filing History |
| 2023-02-10 1:56 pm Sale |
2022-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
EcoR1 Capital, LLC | 3,418,068 7.600% |
-50,876 (-1.47%) |
Filing History |
| 2023-02-09 12:01 pm Sale |
2023-02-09 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
FMR LLC | 4,016,608 10.148% |
-1,890,671 (-32.01%) |
Filing History |
| 2023-02-06 09:50 am Purchase |
2022-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
VICTORY CAPITAL MANAGEMENT INC | 3,459 0.010% |
3,459 (New Position) |
Filing History |
| 2023-01-20 4:09 pm Purchase |
2023-01-13 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
Millennium Management LLC | 2,433,850 5.400% |
2,433,850 (New Position) |
Filing History |
| 2022-12-29 4:41 pm Purchase |
2022-12-23 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
PFIZER INC PFE |
5,376,344 12.000% |
5,376,344 (New Position) |
Filing History |
| 2022-12-27 4:36 pm Sale |
2022-12-22 | 13D | ORIC Pharmaceuticals, Inc. ORIC |
ORBIMED ADVISORS LLC | 1,787,569 4.500% |
-425,002 (-19.21%) |
Filing History |
| 2022-07-08 4:57 pm Sale |
2022-06-30 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
BlackRock Inc. BLK |
799,341 2.000% |
-1,616,006 (-66.91%) |
Filing History |
| 2022-02-14 3:02 pm Purchase |
2021-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
EcoR1 Capital, LLC | 3,468,944 8.800% |
376,726 (+12.18%) |
Filing History |
| 2022-02-11 4:54 pm Sale |
2021-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
The Column Group II, LP | 3,671,522 9.300% |
-1,096,659 (-23.00%) |
Filing History |
| 2022-02-09 10:24 am Purchase |
2022-02-08 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
FMR LLC | 5,907,279 14.999% |
454,932 (+8.34%) |
Filing History |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
BlackRock Inc. BLK |
2,415,347 6.100% |
536,439 (+28.55%) |
Filing History |
| 2022-02-02 3:53 pm Purchase |
2021-12-31 | 13G | McGrath RentCorp MGRC |
VICTORY CAPITAL MANAGEMENT INC | 2,301,232 5.840% |
2,301,232 (New Position) |
Filing History |